Skip to main content

Table 1 Frequency of immunohistochemical detection of CTAs and NY-BR-1 with the corresponding mAbs in breast cancer

From: Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications

 

n

%

MAGE-A1 MA 454

21 (140)

15

mAb M3H67

17 (132)

12,9

mAb 57B

6 (133)

4,5

NY-ESO-1 E978

21 (140)

15

GAGE #26

17 (133)

12,8

MAGE-A 6C1

7 (141)

5

NY-BR-1 #5

61 (131)

46,6

  1. n=number of cases with antigen positivity, in parenthesis total number with successful TMA mapping for each antigen.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us